CANCER CELL PROCOAGULANTS AND THEIR ROLE IN MALIGNANT DISEASE

被引：56

作者：

GORDON, SG

机构：

[1] Dept. of Pathology/Medical Oncology, University of Colorado, Health Sciences Center, Denver, CO 80262

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1992年 / 18卷 / 04期

关键词：

D O I：

10.1055/s-2007-1002580

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：424 / 433

页数：10

共 147 条

[1]

ADANY R, 1989, THROMB HAEMOSTASIS, V62, P850

[2]

ALESSIO MG, 1990, EUR J HAEMATOL, V45, P78

[3] TUMOR INTERACTION WITH HEMOSTASIS - THE RATIONALE FOR THE USE OF PLATELET INHIBITORS AND ANTICOAGULANTS IN THE TREATMENT OF CANCER [J].

ALMONDHIRY, H .

AMERICAN JOURNAL OF HEMATOLOGY, 1984, 16 (02) :193-202

[4]

ANDOH K, 1987, CANCER-AM CANCER SOC, V59, P748, DOI 10.1002/1097-0142(19870215)59:4<748::AID-CNCR2820590414>3.0.CO

[5]

2-E

[6] HUMAN-TISSUE FACTOR CONTAINS THIOESTER-LINKED PALMITATE AND STEARATE ON THE CYTOPLASMICHALF-CYSTINE [J].

BACH, R ;

KONIGSBERG, WH ;

NEMERSON, Y .

BIOCHEMISTRY, 1988, 27 (12) :4227-4231

[7] CHARACTERIZATION OF RAT-TUMOR CELL HYBRIDS - PROCOAGULANT AND FIBRINOLYTIC-ACTIVITIES [J].

BADENOCHJONES, P ;

RAMSHAW, IA .

AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1985, 63 (FEB) :91-98

[8] CULTURED NORMAL HUMAN HEPATOCYTES DO NOT SYNTHESIZE LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR - EVIDENCE THAT ENDOTHELIUM IS THE PRINCIPAL SITE OF ITS SYNTHESIS [J].

BAJAJ, MS ;

KUPPUSWAMY, MN ;

SAITO, H ;

SPITZER, SG ;

BAJAJ, SP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8869-8873

[9]

BAJAJ SP, 1981, J BIOL CHEM, V256, P253

[10]

BASTIDA E, 1987, CANCER RES, V47, P1767

← 1 2 3 4 5 6 7 8 9 10 →